NL-OMON29993CompletedPhase 3
A randomized, open-label, comparative trial to evaluate the effects on ovarian function of a monophasic combined oral contraceptive (COC) containing 2.5 mg nomegestrol acetate (NOMAC) and 1.5 mg estradiol (E2), compared to a monophasic COC containing 3 mg drospirenone (DRSP) and 30 µg ethinyl estradiol (EE). - Dinox Organon trial
Organon Nederland BV0 sites48 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 48
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Healthy women and willing to use a combined contraceptive for 6 cycles.
- •Age at least 18-35 years.
Exclusion Criteria
- •Contraindications for contraceptive steroids
- •Additional contraindications related to the antimineralocorticoid activity of drospirenone
- •Breastfeeding
Investigators
Similar Trials
Active, not recruiting
Phase 1
A randomized, open-label, comparative trial to evaluate the effects on ovarian function of a monophasic combined oral contraceptive (COC) containing 2.5 mg nomegestrol acetate (NOMAC) and 1.5 mg estradiol (E2), compared to a monophasic COC containing 3 mg drospirenone (DRSP) and 30 µg ethinyl estradiol (EE).EUCTR2006-001546-14-NLV Organon48
Active, not recruiting
Phase 1
Dermatitis StudyEUCTR2017-001574-42-Outside-EU/EEAGlaxoSmithKline Research & Development Ltd123
Completed
Phase 3
A clinical trial to study the effects of Recombinant Human Erythropoietin therapy in management of anemia in patients suffering from Chronic Renal Failure.CTRI/2009/091/000786upin Limited India
Recruiting
Phase 4
Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions (DEXA-REFINE)2024-519759-27-00Consorcio Centro De Investigacion Biomedica En Red980
Active, not recruiting
Not Applicable
A comparative, randomised controlled trial for evaluating the efficacy of dexamethasone administration in the treatment of patients with the Acute Respiratory Distress SyndromeAcute respiratory distress syndrome (ARDS)MedDRA version: 14.1Level: PTClassification code 10001052Term: Acute respiratory distress syndromeSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2012-000775-17-ESJesús Villar Hernández